Drugs / Aprepitant (MK-869) + Standard PO
last change Jul 2010 re-read 2 minutes ago

Aprepitant (MK-869) + Standard PO

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT00781768 Comparator Aug 2003 → Oct 2008 Loyola University Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Aprepitant (MK-869) + Standard PO ClinicalTrials.gov intervention name — accepted as the source's own label NCT00781768